Intrinsic Value

The intrinsic value of Pharmx Technologies Ltd (PHX) under the Base Case is 0.069 AUD per share. Compared with the current market price of 0.083 AUD, the stock appears Overvalued by 17% .

The intrinsic value is calculated using valuation multiples.

Do our valuations actually work? See backtest results .

PHX Intrinsic Value
AU$0.069
Overvaluation 17%
Intrinsic Value
Price AU$0.083
P

PHX is valued in line with its history. A premium of this size has been typical over the past 5 years.

Monitor PHX
Get notified when the price drops
Track Buy Zone
20% below Intrinsic Value AU$0.06
Get notified when the price drops into your buy zone
Current Price AU$0.08
Intrinsic Value AU$0.07
Margin of Safety 20% AU$0.06
Or choose another margin of safety
0% below Intrinsic Value
10% below Intrinsic Value
30% below Intrinsic Value
40% below Intrinsic Value
50% below Intrinsic Value
Custom
Alternatives to PHX

Fundamental Analysis

What Pharmx Technologies Does

Technology Information Technology

Pharmx Technologies Ltd runs an electronic ordering platform for the pharmacy supply chain. It connects pharmacies with medicine and health-product suppliers, so buyers can place orders and suppliers can receive and process them in one system instead of using phone calls, emails, or manual paperwork. Its main customers are pharmacies, wholesalers, and other suppliers that sell into pharmacies.

Headquarters
Australia AU
IPO date
Jul 28, 1971
Read the full company overview
View Company Overview
Financials
Efficiency

Earnings Waterfall
Pharmx Technologies Ltd

Wall St Price Targets

Capital Returns

Competitive Landscape

What is the Intrinsic Value of one PHX stock?

The intrinsic value for Pharmx Technologies Ltd (PHX) under the Base Case is 0.069 AUD.

Is PHX stock undervalued or overvalued?

Compared with the current market price of 0.083 AUD, the stock appears Overvalued by 17% .

Back to Top